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Abstract
At times of crisis when epidemics rage and begin to take their toll on affected populations, as we
have been witnessing with African trypanosomiasis in subSahara, the dichotomy of basic versus
applied research deepens. While undoubtedly the treatment of thousands of infected people is the
top priority, without continued research and development on the biology of disease agents and on
ecological and evolutionary forces impacting these epidemics, little progress can be gained in the
long run for the eventual control of these diseases. Here, we argue the need for additional research
in one under-investigated area, that is the biology of the tsetse vector. Lacking are studies aimed
to understand the genetic and cellular basis of tsetse interactions with trypanosomes as well as the
genetic and biochemical basis of its ability to transmit these parasites. We discuss how this
knowledge has the potential to contribute to the development of new vector control strategies as
well as to improve the efficacy and affordability of the existing control approaches.
Introduction
Despite many decades of research on vector-borne para-
sites and their development in mammalian hosts, effec-
tive strategies have yet to materialize for control of any of
the diseases with which they are associated. At the same
time, a heavy reliance on insecticides and therapeutic
drugs has resulted in the spread of insecticide resistance in
many vectors and the emergence of drug resistance in par-
asites, threatening the availability of effective tools to
combat these diseases. This scenario is apparent for sleep-
ing sickness in Africa where there are currently more than
half a million people estimated to have contracted the fa-
tal disease.
Most studies on Human African Trypanosomiasis (HAT)
have centered on the biology of the causative agent,
trypanosomes, as well as on its diagnosis and epidemiol-
ogy. While these research efforts have turned trypano-
somes into a model eukaryote to study novel mechanisms
of gene expression and cell biology, there are no effective
products forthcoming for disease control in the foreseea-
ble future. Trypanosomes' antigenic variation in the mam-
malian host has hampered efforts for vaccine
development. The current strategies for management of
trypanosomiasis depend on active surveillance and treat-
ment of infected hosts, and on limited vector control
measures. These efforts have been restricted due to the
lack of effective drugs, their high cost, adverse side effects,
and the emergence of resistance to these drugs in parasites
[1]. Recently, there has been a welcoming and much need-
ed push for the development of new anti-trypanosomal
drugs, and hopefully these efforts will strengthen the rep-
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ertoire of therapies available for management of this fatal
disease. Nevertheless, strategic difficulties in accessing the
rural populations often inflicted with this disease, the lack
of sensitive diagnostic tools and the potential for emer-
gence of drug resistance in parasites to these new drugs
will continue to threaten the long-term success of these
strategies.
It is important to note that trypanosomiasis is a disease
based on interactions among at least three organisms: the
human, the parasite, and the tsetse fly. Interference with
any of these interactions can prevent disease. The fact that
the parasites rely on a single insect for transmission opens
up many avenues for control via the control of its vector.
In fact, tsetse control strategies have been widely imple-
mented for the management of animal diseases. As do-
mestic animals are now shown to be reservoirs for human
disease transmission as well, treatment of infected pa-
tients alone can not be effective unless vector control is
concurrently implemented [2]. To date, most tsetse con-
trol efforts have been on a small scale involving trapping
and use of insecticide sprays. A recent study looking into
the cost/benefit analysis of various strategies has identi-
fied large scale, area-wide methods as being far more effi-
cient and affordable for long-term tsetse control [3].
The recent advances in molecular technologies and their
application to insects have revolutionized the field of vec-
tor biology although progress in the tsetse field has been
slow. With regards to trypanosomiasis, there are now ge-
nome sequencing programs for the parasite and the ge-
nome of the human host has been deciphered. In
contrast, to date only a handful of tsetse genes have been
identified, while most important proteins with relevance
for insect metabolic pathway, saliva and trypanosome
transmission are still awaiting characterization. This is in
sharp contrast to the vast level of knowledge available for
mosquitoes such as Anopheles gambiae, for which there is
now an international genome sequencing effort in place,
and other vector genome projects are currently being
planned.
For implementing genetic control, much effort has gone
into the development of DNA transformation systems for
the medically and agriculturally important vectors. There
is no doubt that the availability of this technology stands
to revolutionize insect genetics by allowing us to conduct
basic studies for functional characterization of various
genes and their products. It also promises the develop-
ment of alternative control strategies such as transgenic re-
fractory insects. It is contemplated that these genetically
engineered refractory insects can be driven into natural
populations to replace their susceptible counterparts and,
hence, reduce disease transmission. The principles of this
approach are being widely debated among scientists at
large, and to evaluate the efficacy and feasibility of this
strategy, various international committees are currently
being established [4]. In the case of tsetse, the develop-
ment of trypanosome-refractory strains stands to immedi-
ately enhance the efficacy of at least one currently
implemented area-wide control strategy, Sterile Insect
Technique (SIT). While genetic transformation systems
have been now established for various vector insects, the
viviparous reproductive biology of tsetse has hampered
the application of germ-line transformation technology in
this insect. However, in addition to transmitting trypano-
somes, tsetse flies have established symbiotic relation-
ships with multiple maternally transmitted bacteria.
These symbionts provide a unique opportunity for somat-
ic transformation approaches [5]. In this system, anti-
trypanosomal gene products can be expressed in vivo in
the symbionts in midgut and can directly interfere with
the viability of parasites. Our ability to harness this system
at its fullest however depends on a good understanding of
trypanosome transmission in tsetse and the biology of
tsetse symbionts.
Results and Discussion
The ability of tsetse to transmit trypanosomes
Insects have the ability to clear the pathogenic agents they
encounter via a robust innate immune system. At the cent-
er of insect immune reactions is a diverse set of mecha-
nisms ranging from phagocytosis, to activation of
proteolytic cascades, such as coagulation and melaniza-
tion and to production of various antimicrobial peptides
[6,7]. In the absence of memory and adaptive immune de-
fenses, they rely on the recognition of conserved mole-
cules common to specific groups of pathogens. Much of
this response is initiated in the fat body of insects, where
a variety of proteins and peptides with antimicrobial ac-
tivity are synthesized and induce a systemic response to
infection. The activity spectrum of immune peptides is di-
verse and can respond specifically to a pathogen or to var-
ious pathogen groups. In Drosophila and mosquitoes, the
use of different receptor /signaling pathways have been
found to allow for discrimination between different path-
ogen groups, prokaryotic versus eukaryotic. In addition to
fat body, effector molecules, such as nitric oxide and the
phenoloxidase cascade, expressed locally in the midgut
are also increasingly being recognized as playing an im-
portant role in immune reactions in insects [8,9].
Research development in the area of innate immunity has
rapidly progressed in recent years, and the biodiversity of
insects producing complementary information is fortui-
tous for vector biologists struggling to understand the ge-
netic basis of vector-parasite compatibility. For many of
the insect species studied, several genes and proteins have
been characterized as well as the pathways to which they
are tied. However, much of what is known is based on im-Kinetoplastid Biology and Disease 2002, 1 http://kinetoplastids.com/content/1/1/4
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mune responses to bacterial or fungal infections. More ad-
vanced work is underway in the area of mosquito genetics
and has shown that the mosquito is indeed capable of de-
tecting the presence of the malaria parasite and mounting
a pathogen-specific response, suggesting an active control
of the level of Plasmodium infection by the mosquito. In A.
gambiae, analysis of genes expressed in response to Plasmo-
dium infections revealed a range of immune responsive
genes that were upregulated in different tissues and could
be correlated temporally and spatially to the passage of
malarial parasites through the mosquito.
Most species within the four subgenera of Glossina: fusca,
morsitans, palpalis andausteni, are competent vectors for
parasite transmission, although their transmission effi-
ciently varies widely. When one examines the prevalence
of trypanosome infection in natural tsetse populations, it
is apparent that tsetse must also be mounting a significant
level of immune defense, since trypanosome infections
with T. brucei spp. complex parasites are typically detected
in less than 1% of the field population [10–12]. Even un-
der ideal conditions in the laboratory where all flies are
given an infectious blood meal, transmission rates are be-
tween 1–10% depending on the fly species/strain and par-
asite strain [13–16]. The basis for this refractoriness is not
known but is thought to involve complex interactions be-
tween tsetse species, their symbiotic bacteria and the gen-
otype of the strain of the parasite acquired [17].
The life cycle of the trypanosome in the tsetse fly begins
when it feeds from an infected mammalian host. The non-
proliferating short stumpy cells that are pre-adapted for
life in tsetse fly rapidly differentiate into procyclic forms
in the gut lumen, lose their variant surface glycoprotein,
and express a new coat composed of procyclin proteins.
The procyclin coat contributes to the establishment of in-
fections in the fly [18]. It has recently been shown that the
procyclic cells express different procyclin coats during es-
tablishment in the gut and that the N-terminal domain of
all procyclins are quantitatively removed by proteolysis in
the fly, but not in culture [19]. It has also been shown that
the binding of a lectin (concavanalin A) to the procyclin
molecule of the procyclic form cells induces multinuclea-
tion, a disequilibrium between nuclear and kinetoplast
replication and a unique form of cell death [20]. The sur-
viving procyclic cells eventually proliferate in the gut (es-
tablishment phase) and flies can be scored with infections
7–10 days after acquiring an infectious meal. The subse-
quent maturation phase occurs in the salivary glands for
T. brucei and in the mouthparts for T. congolense group par-
asite. Here, they first differentiate into attached proliferat-
ing epimastigote forms which then yield the infective,
free-living metacyclic cells that are transmitted to the next
host during blood-feeding by the fly. It is at this stage that
parasites have been shown to undergo genetic exchange
[21]. The factors triggering this differentiation step are un-
known. There is believed to be a critical period for matu-
ration between days 8 and 11 after infection. One
suggestion is that lectins have a role, since feeding lectin
inhibitory sugars can block maturation. However, it is
clearly crucial to investigate the role of other components
of the immune system.
Figure 1
Regulation of attacin, defensin and diptericin expression in fat body after feeding pathogens in the bloodmeal. Northern blots
were hybridized to GmAttA (A), GmDefA (B) and GmDipA (C) cDNAs and results are also schematically presented. Fat body
RNA was analyzed 8 and 24 h following bloodstream trypanosome feeding (Lanes 1 and 2, respectively), 8 and 24 h after pro-
cyclic trypanosome feeding (Lanes 3 and 4, respectively), 8 and 24 h after E. coli feeding (Lanes 5 and 6, respectively) and 8 and
24 h after a normal bloodmeal (Lane 7 and 8, respectively). This is a representative example of three replicate experiments.Kinetoplastid Biology and Disease 2002, 1 http://kinetoplastids.com/content/1/1/4
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Recently, to understand the role of tsetse immune re-
sponses for trypanosome transmission, we characterized
several immune marker genes (defensin, attacin and dip-
tericin) from tsetse and studied their transcriptional regu-
lation in vivo[22]. These results show that upon entry into
the fly via the bloodmeal, trypanosomes fail to elicit a
strong immune response, contrary to what is seen with Es-
cherichia coli (Figure 1). Furthermore, tsetse immune re-
sponses can differentiate between the blood-stream form
and procyclic parasites. The blood-stream form parasites
which would be, acquired during the course of natural in-
fections in the field, result in significantly less induction
of the immune peptide gene transcription than their pro-
cyclic counterparts.
In other experiments where the parasite was introduced
into the hemolymph of the fly via microinjections, again
there was no upregulation of transcription of these anti-
microbial peptide genes in fat body although similar mi-
croinjections of E. coli resulted in abundant and long-
lasting response [22]. However when we analyzed the
transcriptional expression of these genes in fat body of
flies with established midgut parasite infections, we were
surprised. In these parasite infected flies, the same marker
genes were being expressed abundantly in fat body al-
though apparently their presumably synthesized products
did not affect the viability of the parasites in midgut (Fig-
ure 2). Other flies that had been able to clear their parasite
infections however no longer expressed these peptide
gene transcripts.
These results suggest that initially African trypanosomes
do not evoke an immune response in tsetse – how they do
this is at present unknown. As the parasite numbers in-
crease in the fly gut after establishment in the ectoperi-
trophic space of midgut, they are recognized as foreign
and an immune response is initiated in fat body. Why this
response fails to clear the parasite infections is also un-
known. It is possible that the eukaryotic parasites could be
resistant to the actions of these immune peptides, or alter-
natively the peptides synthesized in fat body and circulat-
ing in the hemolymph might fail to reach and harm the
parasites in their special niche in the midgut. Neverthe-
less, immune events early in the infection process in the
fly appear to be crucial for disease outcome. In fact, in ex-
periments where the immune system of the teneral fly was
stimulated by micro-injection of either E. coli or LPS prior
to providing the infectious parasites in the first blood
meal, the infection rate in tsetse midgut could be substan-
tially lowered (Table 1).
It might be possible to control parasite infections via
transgenics by constitutively expressing in midgut the
products that appear to adversely effect parasite develop-
ment in the immune-challenged flies. These experiments
are providing the first preview into tsetse immune mecha-
nisms. For a complete picture of tsetse responses to
trypanosomes, additional immune responsive genes will
need to be evaluated not only from the fat body but also
from midgut tissue.
Tsetse symbionts as vehicles for transgenics
When gene products that interfere with trypanosome
transmission in the fly are characterized as described
above, constitutive expression of these products would be
desirable in tissues where they can impact parasite viabil-
ity. For these experiments, it is necessary to establish a
DNA transformation system for tsetse. At the core of trans-
genesis is the process of genetic transformation, which for
many insects relies on the microinjection of transposable
elements, which insert themselves into insect DNA (germ-
line transformation). Marker genes carried by the trans-
posable element help identify the transgenic individual
[23]. Tsetse flies, however, have an unusual reproductive
biology. There is no free egg stage; females retain each egg
within the uterus. Following hatching and in utero devel-
opment, one mature larva is deposited. Each female can
deposit 3–4 offspring during its 5–6 week life span in the
field. This viviparous reproductive biology undoubtedly
complicates attempts to transform tsetse through egg mi-
croinjection. However, tsetse flies naturally harbor a
number of symbiotic microorganisms, which can be ex-
ploited to express foreign gene products [5]. Through such
Figure 2
Regulation of attacin, defensin and diptericin expression in fat
body during the course of parasite establishment and the
immuno-competence of parasite infected and infection cured
flies. A: Northern analysis showing gene expression in fat
body 3 and 6 days following a parasite infected bloodmeal
(Lanes 1 and 2, respectively), and after 10 days when flies
were scored as infected (+) or parasite infection cured (-)
(Lanes 3 and 4, respectively). B: Gene expression in fat body
from flies with (Lane 1) and without (Lane 3) gut parasite
infections 20 days after receiving the infectious bloodmeal,
and their immuno-competence after challenge (Lanes 2 and
4, respectively). +, parasite infected; -, parasite cured; N,
naive; I, immune stimulated.Kinetoplastid Biology and Disease 2002, 1 http://kinetoplastids.com/content/1/1/4
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an approach, the insect cells are not transformed as in
germ-line transformation, but instead foreign genes are
expressed in the symbiotic bacteria (somatic transforma-
tion). Since the symbionts live in close proximity to the
developing trypanosomes, anti-pathogenic products ex-
pressed in these cells could adversely affect parasite trans-
mission.
It has been shown that tsetse flies harbor three distinct or-
ganisms[5]. Two of these are present in the gut tissue; the
obligate Wigglesworthia glossinidia and the facultative Soda-
lis glossinidius. Both of these symbionts are enteric bacteria
closely related to E. coli. The third symbiont harbored in
certain tsetse species is Wolbachia, an obligate intracellular
bacteria closely related to Rickettsia[24,25]. Vertical trans-
mission of Wolbachia is accomplished by transovarial
transmission, whilst the other symbionts are transmitted
through milk-gland secretions during the nourishment of
the developing larva [26,27]. Wigglesworthia has been im-
plicated to provide the fly vitamin metabolites missing
from its single diet, blood [28] and recent molecular anal-
ysis has shown that its small genome indeed contains an
unusually high number of genes in the vitamin biosyn-
thetic pathways[29].
It has been possible to cultivate the Sodalis symbiont in vit-
ro[30], and a genomic transformation system has been de-
veloped [31]. It has also been possible to reconstitute
tsetse with the recombinant Sodalis, and the recombinant
symbiont has been shown to be successfully acquired by
the intrauterine progeny [26]. Now effective gene prod-
ucts need to be identified that can have anti-trypanosomal
effects when expressed in Sodalis in tsetse midgut. The
constitutive expression of the tsetse immune-responsive
molecules, which trypanosomes apparently down-regu-
late to achieve their transmission early in the infection
process, might provide one such approach. The identifica-
tion of monoclonal antibodies (mAbs) with parasite
transmission blocking characteristics and their expression
as single-chain antibody gene fragments in the symbionts
provides an alternative avenue. Towards this end several
transmission-blocking antibodies targeting the major sur-
face protein of the insect stage procyclic trypanosomes
have already been reported [32].
The relative ease of genetic transformation and gene ex-
pression in bacteria, and the multitude of potential an-
tiparasitic targets which can be explored, makes this a
desirable system for transgenic approaches. Should resist-
ance develop in parasites against any of the expressed for-
eign gene products, it would be relatively easy to switch to
express a different gene product. Alternatively, several tar-
get genes can potentially be expressed simultaneously in
the symbionts to prevent the development of resistance
against any one individual target.
Application of transgenics for disease control
In order to interfere with disease transmission, the even-
tual goal of any transgenic approach is to replace the nat-
urally susceptible population with their engineered
refractory counterparts. One powerful potential driving
system involves the use of Wolbachia symbionts, which
confer a reproductive advantage to their hosts. Genetically
engineered females carrying Wolbachia would thus have
an advantage over uninfected, non-engineered females
and spread more rapidly through the population.
The functions of Wolbachia in the various hosts they infect
are variable. One common reproductive abnormality they
induce has been termed cytoplasmic incompatibility (CI),
which when expressed results in embryonic death due to
disruptions in early fertilization events [33]. In an incom-
patible cross, the sperm enters the egg but does not suc-
cessfully contribute its genetic material to the potential
zygote. In most species, this results in a low number of vi-
able eggs. The infected females have a reproductive advan-
tage, over their uninfected counterparts, because they
produce progeny after mating with both Wolbachia-infect-
ed and uninfected males. This reproductive advantage al-
lows Wolbachia to spread into populations. In D. simulans
in the central California valley, a natural Wolbachia infec-
tion invading naïve, uninfected populations has spread at
Table 1: Trypanosome infection prevalence in G. m. morsitans after immune activation with Bacteria, Lipopolysaccharide (LPS) or Ster-
ile Phosphate Buffered Saline (PBS)
Inoculation Pooled N Prevalence (Std.error) χ 2 analysis1
Control 145 49.7% (5.0) -
E. coli 99 11.1% (5.1) P < 0.0001
LPS 152 27.0% (2.5) P < 0.0001
PBS 106 50.0% (9.6) P = 0.94
Note. Numbers represent pooled samples from replicates for each treatment. The infection prevalence in the control groups served as the 
expected data against which other groups were tested.Kinetoplastid Biology and Disease 2002, 1 http://kinetoplastids.com/content/1/1/4
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a rate of over 100 km per year simply through the expres-
sion of CI [34]. In order to understand the functional role
of Wolbachia in insects, it has been possible to cure most
insects of their Wolbachia infections by administering an-
tibiotics in their diet. This approach, however, has not
been feasible in tsetse, since the antibiotic treatment re-
sults in the clearing of all bacterial symbionts, including
the obligate symbiont Wigglesworthia, and in the absence
of these, the flies become sterile. In order to study CI ex-
pression in tsetse, uninfected flies need to be collected
from the field and colonized so that appropriate mating
experiments can be performed in the laboratory. As Wol-
bachia infected insects replace naive populations by virtue
of the CI phenomena, they can drive other maternally in-
herited elements, such as the maternally inherited gut-
symbionts Sodalis of tsetse into that same population. It
has been proposed that multiple Wolbachia infections, in
which an insect contains two or more different Wolbachia
strains that are incompatible with each other, could be
used to generate repeated population replacements or to
spread Wolbachia into target species that already contain
an existing infection [35,36]. The analysis of Wolbachia
strain types infecting different species of tsetse has shown
that they are different and as such represent independent
acquisitions [24].
Figure 3
Symbiont-based transgenic approaches. The cultivation, genetic transformationand reintroduction of recombinant symbionts to
tsetse by micro injection is schematically depicted.Kinetoplastid Biology and Disease 2002, 1 http://kinetoplastids.com/content/1/1/4
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One vector control strategy that stands to benefit from en-
gineered parasite refractory fly lines and from Wolbachia
mediated mating sterility is Sterile Insect Technique (SIT).
SIT is a genetic population suppression approach and in-
volves sustained, systematic releases of irradiated sterile
male insects among the wild population. Releasing sterile
males in high numbers over a period of 3–4 generations,
after having reduced population density by other tech-
niques (trapping, insecticide spraying etc.), the target pop-
ulation can be eradicated [37,38]. There has been an
ongoing debate on the effectiveness of SIT strategy for
continent wide tsetse control given the high cost and time
associated with mass rearing the large numbers of sterile
males needed, and the potential for re-invasion of areas
cleared of tsetse [39]. While it may indeed be difficult to
employ SIT in all tsetse habitats, it may be a very efficient
and important tool within the context of an Integrated
Tsetse Management Program. The recent successful eradi-
cation of G. austeni from the island of Zanzibar using such
an integrated approach of population suppression fol-
lowed by SIT has demonstrated the feasibility of this tech-
nology where applicable [38]. Whether total eradication
can ever be achieved or not has been and will continue to
be debated, however the Zanzibar project has clearly
shown that SIT can be a valuable vector management tool
for selective foci. It is likely that the continued monitoring
of vector populations is still desirable for SIT similar to
other control techniques.
Improvements in two aspects of the current SIT technolo-
gy have the potential to enhance its efficacy for future pro-
grams [40]. The first is the development of parasite
refractory strains. Since the large numbers of male flies re-
leased can potentially contribute to a temporary increase
in disease transmission, the incorporation of refractory
traits into the SIT release strains will greatly enhance the
efficacy of this approach, especially in human disease en-
demic foci. During the current field SIT programs, male
tsetse are provided with a blood meal containing a
trypanocide before release and no infections have been so
far found in trapped released sterile males.
The second is the use of Wolbachia mediated CI as a meth-
od of inducing sterility as an alternative to irradiation.
With CI, the release strain of tsetse would carry a Wol-
bachia infection that would induce CI when males are
mated with wild females. The competitiveness of these
males would be expected to be much higher than irradiat-
ed males and as a result fewer insects would need to be re-
leased in order to achieve the same level of sterility in the
wild population, decreasing the cost of the approach sig-
nificantly. This strategy is dependent on the use of a very
efficient sexing system. If Wolbachia-infected females are
released in sufficient quantities, then Wolbachia would
have the opportunity to invade the target population,
which would render subsequent releases ineffective. If it
were impossible to guarantee extremely low quantities of
released females, then it would be possible to incorporate
low levels of irradiation with Wolbachia induced sterility
to prevent released females from successfully reproducing.
This approach has been successfully tested in Culex mos-
quitoes [41].
Conclusions
Understanding the molecular and cellular basis of
trypanosome transmission in tsetse is of fundamental sig-
nificance, but in addition these experiments can result in
new applications for vector control. Since the symbiont-
based transformation system can be used with ease to ex-
press gene products in tsetse midgut, these studies are also
of significance to identify candidate genes that can be ex-
pressed to confer refractoriness in tsetse (Schematically
shown in Figure 3). From the preliminary studies with the
tsetse immune system, it appears that trypanosomes have
developed abilities to also manipulate their insect host to
mediate their transmission. In future experiments, one of
our goals is to understand how this very heightened im-
mune sensitivity in the parasite infected tsetse host affects
its viability and fecundity.
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